Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4340-4346

  Xiu, Yan ^a   Nakamura, Kazuhiro ^a   Abe, Masaaki ^a   Li, Na ^a   Wen, Xiang Shu ^a   Jiang, Yi ^a   Zhang, Danqing ^a   Tsurui, Hiromichi ^a   Matsuoka, Shuji ^a   Hamano, Yoshitomo ^a   Fujii, Hiroyuki ^a   Ono, Masao ^a   Takai, Toshiyuki ^a   Shimokawa, Toshibumi ^a   Ra, Chisei ^a   Shirai, Toshikazu ^a   Hirose, Sachiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BINDING PROTEIN; FC GAMMA RECEPTOR 2B1; FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; LUCIFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEEDBACK SYSTEM; GENE DELETION; GENE EXPRESSION; HUMORAL IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0037108491     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4340     Document Type: Article

References (36)

1. Ravetch, J. V. 1994. Fc receptors: rubor redux. Cell 78:553.
2. Daëron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203.
3. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76:231.
4. Coggeshall, K. M. 1998. Inhibitory signaling by B cell FcγRIIb. Curr. Opin. Immunol. 10:306.
5. Hirose, S., Y. Jiang, Y. Hamano, and T. Shirai. 2000. Genetic aspects if inherent B-cell abnormalities associated with SLE and B-cell malignancy: lessons from New Zealand mouse models. Int. Rev. Immunol. 19:389.
6. Goodnow, C. C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93:2264.
7. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
8. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
9. Vyse, T. J., S. J. Rozzo, C. G. Drake, S. Izui, and B. L. Kotzin. 1997. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand Black mice. J. Immunol. 158:5566.
10. Jiang, Y., S. Hirose, R. Sanokawa-Akakura, M. Abe, X. Mi, N. Li, Y. Miura, J. Shirai, D. Zhang, Y. Hamano, and T. Shirai. 1999. Genetically determined aberrant down-regulation of FcγRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol. 11:1685.
11. Haywood, M. E. K., M. B. Hogarth, J. H. Slingsby, S. J. Rose, P. J. Allen, E. M. Thompson, M. A. Maibaum, P. Chandler, K. A. Davies, E. Simpson, et al. 2000. Identification of intervals on chromosome 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 43:349.
12. Xie, S., S.-H. Chang, P. Yang, C. Jacob, A. Kaliyaperumal, S. K. Datta, and C. Mohan. 2001. Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J. Immunol. 167:7141.
13. Tsao, B. P. 2000. Lupus susceptibility genes on human chromosome 1. Int. Rev. Immunol. 19:319.
14. Jiang, Y., S. Hirose, M. Abe, R. Sanokawa-Akakura, M. Ohtsuji, X. Mi, N. Li, Y. Xiu, D. Zhang, J. Shirai, et al. 2000. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51:429.
15. Bonnerot, C., V. Choukroud, M.-A. Marloie, and W. H. Fridman. 1992. Two distinct regions of the mouse β FcγR gene control its transcription. Immunobiology 185:222.
16. Hogarth, P. M., E. Witort, M. D. Hulett, C. Bonnerot, J. Even, W. H. Fridman, and I. F. C. McKenzie. 1991. Structure of the mouse β Fcγ receptor II gene. J. Immunol. 146:369.
17. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681.
18. Pritchard, N. R., A. J. Cutler, S. Uribe, S. J. Chadban, B. J. Morley, and K. G. C. Smith. 2000. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10:227.
19. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346.
20. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327.
21. Schreiber, E., P. Matthias, M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acid Res 17:6419.
22. Fujihara, M., S. Wakamoto, T. Ito, M. Muroi, T. Suzuki, H. Ikeda, and K. Ikebuchi. 2000. Lipopolysaccharide-triggered desensitization of TNF-α mRNA expression involves lack of phosphorylation of IκBα in a murine macrophage-like cell line, P388DI. J. Leukocyte Biol. 68:267.
23. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
24. Mermod, N., T. J. Williams, and R. Tjian. 1988. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332: 557.
25. Luan, J. J., R. C. Monteiro, C. Sautès, G. Fluteau, L. Eloy, W. H. Fridman, J.-F. Bach, and H.-J. Garchon. 1996. Defective FcγRII gene expression in macrophages of NOD mice. J. Immunol. 157:4707.
26. Yu, L., D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and DOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA 97:1701.
27. Greeley, S. A. W., M. Katsumata, L. Yu, G. S. Eisenbarth, D. J. Moore, H. Goodarzi, C. F. Barker, A. Naji, and H. Noorchashm. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8:399.
28. Balland, S., and J. V. Ravetch. 2000. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13:277.
29. Shirai, T., and S. Hirose. 2000. Genetics of SLE; a sine qua non for identification. Int. Rev. Immunol. 19:289.
30. Shirai, T., H. Nishimura, Y. Jiang, and S. Hirose. 2002. Genome screening for susceptibility loci in systemic lupus erythematosus. Am. J. Pharmacogenomics 2:1.
31. Hirose, S., Y. Jian, Y. Haman, and H. Nishimura. 2002. Genetic basis of systemic lupus erythematosus. Med. Actual. 38:167.
32. Boackle, S. A., V. M. Holers, X. Chen, G. Szakonyi, D. R. Karp, E. K. Wakeland, and L. Morel. 2001. Cr2. a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775.
33. Morel. L., K. R. Blenman, B. P. Croker, and E. K. Wakeland. 2001. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. USA 98:1787.
34. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus erythematosus. Immunity 15:435.
35. z homozygous inbred strains of mice derived from New Zealand Black and New Zealand White mice: origins and initial characterization. Lab. Invest. 68:419.
36. Giniger, E., S. M. Varnum, and M. Ptashne. 1985. Specific DNA binding of GAL4, a positive regulatory protein of yeast. Cell 40:767.